Literature DB >> 15555051

Protective effects of a free radical scavenger, MCI-186, on high-glucose-induced dysfunction of human dermal microvascular endothelial cells.

Jiaoyun Dong1, Dong Jiaojun, Yoshihiro Takami, Hideharu Tanaka, Ryo Yamaguchi, Guo Jingping, Qing Chun, Lu Shuliang, Shuji Shimazaki, Ken Ogo.   

Abstract

Functional damage to microvascular endothelial cells by hyperglycemia is thought to be one of the critical risk factors in the impaired wound healing seen with diabetes mellitus. It is also thought that free radical stress plays a significant role in this endothelial cell dysfunction. In the present study, the effect of a free radical scavenger, MCI 186, on the endothelial cell dysfunction of cultured cells induced by high-glucose conditions was studied. Human dermal microvascular endothelial cells were cultured with high-glucose medium (50 mM) with or without MCI-186 (10 microM) for 7 days. Fifty mM mannitol was used as an osmotic control in this study. After this treatment, cell proliferation, activation of mitogen-activated protein kinase (MAPK), the level of apoptosis, and caspase-3 activation induced by removal of growth factors or tumor necrosis factor-alpha treatment were studied. High-glucose conditions significantly decreased cell proliferation and increased apoptosis levels with the activation of caspase-3 induced by growth factor removal. The high-glucose condition significantly activated MAPK. MCI-186 treatment improved cellular proliferation and reduced apoptosis and caspase-3 activation induced by high-glucose conditions. MCI-186 also inhibited the activation of MAPK. On the other hand, MCI-186 did not alter the level of apoptosis and caspase-3 activation induced by TNF-alpha treatment. In conclusion, we suggest that MCI-186 may be beneficial for improving the endothelial cell dysfunction induced by hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555051     DOI: 10.1111/j.1067-1927.2004.12607.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  4 in total

1.  Edaravone protects PC12 cells from ischemic-like injury via attenuating the damage to mitochondria.

Authors:  Ying Song; Meng Li; Ji-cheng Li; Er-qing Wei
Journal:  J Zhejiang Univ Sci B       Date:  2006-09       Impact factor: 3.066

Review 2.  Improving Wound Healing with Topical Gene Therapy.

Authors:  John Layliev; Stelios Wilson; Stephen M Warren; Pierre B Saadeh
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-10       Impact factor: 4.730

3.  Edaravone offers neuroprotection for acute diabetic stroke patients.

Authors:  J Zheng; X Chen
Journal:  Ir J Med Sci       Date:  2015-11-23       Impact factor: 1.568

Review 4.  The molecular biology in wound healing & non-healing wound.

Authors:  Chun Qing
Journal:  Chin J Traumatol       Date:  2017-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.